Rate of Confirmed Macular Oedema With Ozanimod in Patients With Relapsing Multiple Sclerosis: Results From the Ozanimod RMS Clinical Development Program-MedSci.cn

Rate of Confirmed Macular Oedema With Ozanimod in Patients With Relapsing Multiple Sclerosis: Results From the Ozanimod RMS Clinical Development Program

Gross, SA; Minton, N; Sheffield, JK; Henry, A; Calkwood, J; Selmaj, KW

EUROPEAN JOURNAL OF NEUROLOGY, 2020; 27 (): 919

科室
- - 订阅+
  - 更多科室
工具
服务